Sareetha Kailayangiri

6PUBLICATIONS
27CO-AUTHORS
Chemical engineering designHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2024
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.

Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann

|Oct 14, 2022
Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma.

Sebastian Fuest, Christoph Post, Sebastian T Balbach

|May 14, 2022
The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies.

Malcolm Holterhus, Bianca Altvater, Sareetha Kailayangiri

|Nov 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes.

Ramona Erber, Sareetha Kailayangiri, Hanna Huebner

|May 03, 2020
Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers.

Sareetha Kailayangiri, Bianca Altvater, Malena Wiebel

Pageof 1